| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 18.9 | 14.0 |
| Gross profit | 10.0 | 7.4 |
| Profit before tax | -4.6 | -14.9 |
| Net income | -4.6 | -15.0 |
| EPS (diluted, $ a share) | $-0.11 | $-0.41 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +35.3% |
|---|---|
| Gross margin | 52.9% |
| Operating margin | -28.9% |
10-Q filed with the SEC, NASDAQ: MASS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
908 Devices Inc.: key numbers
- Share price
- $9.19Close, Nov 16
- Market cap
- $382M
- Shares outstanding
- 41.58MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Laboratory Analytical InstrumentsSIC 3826
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from 908 Devices Inc.
All →908 Devices Earnings Call: Key Takeaways
908 Devices delivered a record Q3 with 35% revenue growth, raising the low end of guidance while integrating Near-Lab and preparing for next-gen MX-908 launches.
- Call
- Nov 10, 2026, 8:30 AM ET
908 Devices Financial Results
908 Devices reported record third-quarter revenue of $19.0 million, a 35% increase year-over-year, driven by strong demand for its FTIR portfolio and the addition of NIRLab revenue. The company achieved a record 308 device shipments in the quarter and raised the low end of its full-year 2026 revenue guidance to a range of $68.5 million to $70.0 million.
- Term
- Q3 2026
“We had a strong third quarter, driven by our FTIR portfolio, with revenue growing 35% year-over-year to $19 million and device shipments reaching a new company record.”
Kevin J. Knopp, CEO and Co-founder
“Our proven platforms are winning orders across the globe as customers accelerate efforts to modernize their detection capabilities and stay ahead of an evolving threat landscape.”
Kevin J. Knopp, CEO and Co-founder
908 Devices Director Christopher D. Brown Sells $328K of Stock
Christopher D. Brown, Director, sold 30,000 shares of 908 Devices Inc. at $10.95 a share, worth $328K in total on Nov 4, 2026. Shares held after the trade: 775,559 (-3.7%).
- Value
- $328K
- Shares
- 30,000
- Price
- $10.95
- Role
- Director
- Holding change
- -3.7%
- Trade date
- Nov 4, 2026
908 Devices Director Christopher D. Brown Sells $357K of Stock
Christopher D. Brown, Director, sold 30,000 shares of 908 Devices Inc. at $11.89 a share, worth $357K in total on Oct 7, 2026. Shares held after the trade: 745,559 (-3.9%).
- Value
- $357K
- Shares
- 30,000
- Price
- $11.89
- Role
- Director
- Holding change
- -3.9%
- Trade date
- Oct 7, 2026
908 Devices CFO Joseph H. Griffith IV Sells $65.2K of Stock
Joseph H. Griffith IV, CFO, sold 5,000 shares of 908 Devices Inc. at $13.03 a share, worth $65.2K in total on Oct 6, 2026. Shares held after the trade: 116,497 (-4.1%).
- Value
- $65.2K
- Shares
- 5,000
- Price
- $13.03
- Role
- CFO
- Holding change
- -4.1%
- Trade date
- Oct 6, 2026
908 Devices Insider AWM Investment Company Inc. Sells $207K of Stock
AWM Investment Company Inc. sold 18,000 shares of 908 Devices Inc. at $11.52 a share, worth $207K in total on Sep 29, 2026. Shares held after the trade: 4,736,773 (-0.4%).
- Value
- $207K
- Shares
- 18,000
- Price
- $11.52
- Holding change
- -0.4%
- Trade date
- Sep 29, 2026